Hikma Pharmaceutical | HIK - Pre Tax Profit


Hikma Pharmaceutical reported $147.5M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Almirall EUR 30.32M 22M Dec/2025
argenx SE USD 426M 22.71M Mar/2026
AstraZeneca USD 4.81B 894M Jun/2026
Autolus Therapeutics Ltd USD -70.73M 20.78M Mar/2026
Bayer EUR 321M 2.67B Jun/2026
Fresenius EUR 535M 42M Jun/2026
Genmab DKK 295M 221M Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
GRIFOLS EUR 247M 135M Jun/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Lonza CHF 624M 197M Dec/2024
Merck EUR 869M 468M Mar/2026
Orion EUR 113.4M 213.6M Mar/2026
Recordati EUR 161.16M 39.6M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sanofi EUR 837M 1.17B Jun/2026
UCB EUR 789M 427M Jun/2025